Form 4: Axon Enterprise CPO & CTO, Jeffrey C. Kunins, Sells Shares in Multiple Transactions
SEC Form 4 Filing
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a total of 38,668 shares of common stock across multiple transactions on November 12th and 13th, 2024.
Summary
- Jeffrey C. Kunins, the Chief Product and Technology Officer of Axon Enterprise, Inc., has sold a significant number of shares.
- The sales occurred over two days, November 12th and 13th, 2024.
- On November 12th, Mr. Kunins sold 21,134 shares in multiple transactions at prices ranging from $591.82 to $596.39.
- On November 13th, he sold 17,534 shares in multiple transactions at prices ranging from $604.44 to $612.81.
- The weighted average sale prices for each transaction are provided in the document.
- Following these transactions, Mr. Kunins directly owns 132,560 shares of Axon common stock.
Sentiment
Score: 4
Explanation: The document itself is neutral, but the sale of shares by a high-ranking executive could be interpreted as a slightly negative signal by the market.
Negatives
- The sale of a significant number of shares by a high-ranking executive could be perceived negatively by the market.
Risks
- Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is not always the case.
- Large sales by insiders can potentially put downward pressure on the stock price.
Industry Context
This is a standard SEC Form 4 filing, which is required when company insiders trade their company's stock. It is a common occurrence and part of the regulatory framework for public companies.
Comparison to Industry Standards
- Form 4 filings are a standard practice for all publicly traded companies in the US, including Axon's competitors such as Motorola Solutions and Digital Ally.
- The volume of shares sold by Mr. Kunins is not unusual for executive stock transactions, but the market reaction will depend on the overall context and investor sentiment.
Stakeholder Impact
- Shareholders may react to the news of the executive stock sale, potentially impacting the stock price.
- The sale could be viewed as a lack of confidence by some investors.
Key Dates
| Date | Description |
|---|---|
| 11/12/2024 | Date of the first set of stock sales by Jeffrey C. Kunins. |
| 11/13/2024 | Date of the second set of stock sales by Jeffrey C. Kunins. |
| 11/14/2024 | Date the Form 4 was signed. |
Keywords
Axon, stock sale, insider trading, Jeffrey C. Kunins, CPO, CTO, executive, share disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.